Cytomegalovirus resistance. Public health implications of CMV prophylaxis and treatment in the HIV patient population.
Frost
K R
KR
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000517:prevention & control; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000187:drug effects / Q000235:genetics; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000517:prevention & control; D004343:Drug Implants; D004352:Drug Resistance, Microbial; D006801:Humans; D009154:Mutation
D000998:Antiviral Agents; D004343:Drug Implants